- High mortality risk predictors in patients with anti-MDA5 dermatomyositis include:
- rapidly progressive interstitial lung disease
- anti-Ro52 antibody
- age > 57 years
(based on study of 126 MDA-5+ DM pts)
https://t.co/8bw1zpEOIh https://t.co/LKXMYtr7hU
Links:
Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly…
https://bit.ly/3TAAsfg
Dec-20-2023
